ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.741,03
-0,08%
Dow Jones
42.366,42
0,45%
Euro vs US Dollar
1,11665
-0,09%
Bitcoin
65.773,28
0,90%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Boston Scientific Corporation (BSX)

  7. Boston Scientific Corporation (BSX) News

BSX

Boston Scientific (BSX)

Boston Scientific Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:BSX
DatumZeitQuelleÜberschriftSymbolFirma
27/09/202413h00PR Newswire (US)Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE™ Pulsed Field Ablation SystemNYSE:BSXBoston Scientific Corporation
17/09/202414h31PR Newswire (US)Boston Scientific Closes Acquisition of Silk Road Medical, Inc.NYSE:BSXBoston Scientific Corporation
17/09/202413h00PR Newswire (US)Boston Scientific Receives FDA Approval for Expanded Indication of INGEVITY™+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch AreaNYSE:BSXBoston Scientific Corporation
27/08/202412h57PR Newswire (US)Boston Scientific Obtains CE Mark for ACURATE Prime™ Aortic Valve SystemNYSE:BSXBoston Scientific Corporation
13/08/202414h00PR Newswire (US)Boston Scientific to Participate in Wells Fargo's 2024 Healthcare ConferenceNYSE:BSXBoston Scientific Corporation
30/07/202422h05PR Newswire (US)Boston Scientific Elects David Habiger to Board of DirectorsNYSE:BSXBoston Scientific Corporation
24/07/202412h30PR Newswire (US)Boston Scientific Announces Results for Second Quarter 2024NYSE:BSXBoston Scientific Corporation
01/07/202414h00PR Newswire (US)Boston Scientific Announces Conference Call Discussing Second Quarter 2024 ResultsNYSE:BSXBoston Scientific Corporation
18/06/202419h23PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.NYSE:BSXBoston Scientific Corporation
18/06/202413h00GlobeNewswire Inc.Silk Road Medical Announces Definitive Agreement to be Acquired by Boston ScientificNYSE:BSXBoston Scientific Corporation
18/06/202413h00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.NYSE:BSXBoston Scientific Corporation
18/05/202417h03PR Newswire (US)MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy EndpointsNYSE:BSXBoston Scientific Corporation
08/05/202422h00PR Newswire (US)Boston Scientific Elects Dr. Cheryl Pegus to Board of DirectorsNYSE:BSXBoston Scientific Corporation
24/04/202413h31IH Market NewsU.S. Futures Display Mixed Results Amid Earnings, WTI and Brent Crude Prices Dip in June Futures TradingNYSE:BSXBoston Scientific Corporation
24/04/202412h30PR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NYSE:BSXBoston Scientific Corporation
08/04/202406h00PR Newswire (US)Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software ModuleNYSE:BSXBoston Scientific Corporation
01/04/202414h00PR Newswire (US)Boston Scientific Announces Conference Call Discussing First Quarter 2024 ResultsNYSE:BSXBoston Scientific Corporation
01/03/202412h55PR Newswire (US)Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated BalloonNYSE:BSXBoston Scientific Corporation
27/02/202422h15PR Newswire (US)Boston Scientific Announces Completion of €2.0 Billion Offering of Senior NotesNYSE:BSXBoston Scientific Corporation
23/02/202403h27PR Newswire (US)Boston Scientific Announces Pricing of €2.0 Billion of Senior NotesNYSE:BSXBoston Scientific Corporation
05/02/202414h00PR Newswire (US)Boston Scientific to Participate in TD Cowen's 44th Annual Health Care ConferenceNYSE:BSXBoston Scientific Corporation
31/01/202412h30PR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NYSE:BSXBoston Scientific Corporation
31/01/202412h29IH Market NewsU.S. Futures Waver Ahead of Fed Decision Amid Mixed Corporate Earnings; Oil Prices SlideNYSE:BSXBoston Scientific Corporation
31/01/202412h25PR Newswire (US)Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation SystemNYSE:BSXBoston Scientific Corporation
08/01/202422h55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NYSE:BSXBoston Scientific Corporation
08/01/202417h36Dow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNYSE:BSXBoston Scientific Corporation
08/01/202413h41Dow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNYSE:BSXBoston Scientific Corporation
08/01/202413h00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NYSE:BSXBoston Scientific Corporation
08/01/202413h00Business WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNYSE:BSXBoston Scientific Corporation
05/01/202414h00PR Newswire (US)Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
 Showing the most relevant articles for your search:NYSE:BSX

Kürzlich von Ihnen besucht

NASDAQ
TRSG
Tungray Technologies
TG
4WF
Wharf Real Estate Invest...
EU
Y546S
Y546S
COIN
BLUEBTC
LSE
FO39
Citi Fun 24
TSXV
CEL.H
Columbus Energy
USOTC
LSHYS
Landa App (GM)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten